Results 151 to 160 of about 3,138,708 (171)
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-targeted therapy that induces rapid cancer cell death by systemically administering an antibody-photoabsorber conjugate (APC) that binds to cancer cells and irradiating NIR
Hiroshi Fukushima +2 more
exaly +4 more sources
Near Infrared Photoimmunotherapy for Lung Metastases [PDF]
Lung metastases are a leading cause of cancer related deaths; nonetheless current treatments are limited. Near infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that combines the specificity of intravenously injected antibodies that target tumors with the toxicity induced by photosensitizers activated by NIR-light.
Tadanobu Nagaya +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Near-infrared photoimmunotherapy for the treatment of skin disorders
Expert Opinion on Biological Therapy, 2021Near-Infrared Photoimmunotherapy (NIR-PIT) is a novel molecularly targeted phototherapy. This technique is based on a conjugate of a near-infrared photo-inducible molecule (antibody-photon absorber conjugate, APC) and a monoclonal antibody that targets a tumor-specific antigen. To date, this novel approach has been successfully applied to several types
Russo I +5 more
openaire +3 more sources
Near-infrared photoimmunotherapy and anti-cancer immunity
International Immunology, 2023Abstract The activation of the anti-cancer immune system is an important strategy to control cancer. A new form of cancer phototherapy, near-infrared photoimmunotherapy (NIR-PIT), was approved for clinical use in 2020 and uses IRDye® 700DX (IR700)-conjugated antibodies and NIR light.
Kohei Nakajima, Mikako Ogawa
openaire +2 more sources
Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective cancer treatment that employs an antibody photoabsorber conjugate (APC) composed of a targeting monoclonal antibody (mAb) conjugated with a photoactivatable phthalocyanine-derivative dye ...
Hiroaki Wakiyama +2 more
exaly +2 more sources
Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
Journal of Visualized Experiments, 2021The efficacy of photoimmunotherapy can be evaluated more accurately with an orthotopic mouse model than with a subcutaneous one. A pleural dissemination model can be used for the evaluation of treatment methods for intrathoracic diseases such as lung cancer or malignant pleural mesothelioma.
Hirotoshi, Yasui +5 more
openaire +2 more sources
Near Infrared Photoimmunotherapy for Cancer
Conference on Lasers and Electro-Optics, 2019Near infrared photoimmunotherapy (NIR-PIT) is a molecularly-targeted cancer photo-therapy based on antibody-photoabsorber (IR700) conjugates. By crashing cancer cells combined with innate and/or adjuvant immune-activation, NIR-PIT activates anti-cancer immunity resulted in curing local and metastatic cancers.
openaire +2 more sources
Near-infrared photoimmunotherapy for salivary duct carcinoma
Auris Nasus LarynxIn Japan, near-infrared photoimmunotherapy (NIR-PIT) was introduced in 2021 as a treatment option for unresectable recurrent head and neck cancer. The treatment targets the epidermal growth factor receptor (EGFR), which is overexpressed in 80-90 % of head and neck squamous cell carcinoma (HNSCC).
Takuma Makino +5 more
openaire +2 more sources
Near-infrared photoimmunotherapy: basics and clinical application
Japanese Journal of Clinical OncologyAbstract Use of antibody–drug conjugates (ADCs) is rapidly increasing in the field of oncology. While ADCs exhibit strong and cell-selective cytotoxicity, they do not show spatial selectivity. Near-infrared photoimmunotherapy (NIR-PIT, Alluminox™) utilizes photoactivatable ADCs, that is, antibody–photoabsorber conjugates (APCs).
Ryuhei Okada, Takahiro Asakage
openaire +2 more sources
2022
Near-infrared photoimmunotherapy (NIR-PIT) is a cell-specific cancer therapy in which antibody-photoabsorber conjugates (APCs) are activated by NIR light to induce rapid immunogenic cell death with minimal off-target effects. In preclinical settings, bioluminescence imaging (BLI) is useful to quantitatively assess the efficacy of NIR-PIT for both in ...
Ryuhei, Okada +3 more
openaire +2 more sources
Near-infrared photoimmunotherapy (NIR-PIT) is a cell-specific cancer therapy in which antibody-photoabsorber conjugates (APCs) are activated by NIR light to induce rapid immunogenic cell death with minimal off-target effects. In preclinical settings, bioluminescence imaging (BLI) is useful to quantitatively assess the efficacy of NIR-PIT for both in ...
Ryuhei, Okada +3 more
openaire +2 more sources

